stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Phibro Animal Health Corporation

United States 路 NASDAQ:聽PAHC 路 Market cap: 路 P/E: 路 P/S:

Phibro makes medicines, vaccines, and nutritional ingredients that keep farm animals and pets healthy.

Phibro Animal Health is a company that sells medicine and nutrition for animals, mostly the ones raised for food. It sells to livestock producers, veterinarians, and people with pets. Its core products are animal health medicines and vaccines, plus a mineral nutrition business that makes feed ingredients like zinc and manganese for livestock diets, and it also makes specialized ingredients for other industries. So it has three main pieces: animal health, mineral nutrition, and performance products.

The money flows in when a chicken farmer, dairy farmer, or vet buys a product to keep animals healthy or growing efficiently. Farmers choose Phibro because healthy animals grow better and cost less to raise, and because in many cases regulation forces them to use proper medicines and medicated feed. Poultry is its biggest customer group. Phibro's vaccines and medicines help prevent disease before it spreads through a flock or herd, which matters when thousands of animals live together. The business is not glamorous, and it comes with real complications. About half of Phibro's revenue runs through its mineral nutrition segment, which is mostly low-margin commodity ingredient sales, so profit is thinner than the animal health side. The company has also faced scrutiny over a product called Mecadox, used to prevent disease in pigs, which regulators in some markets have questioned. Competitors include much bigger players like Zoetis and Merck's animal health arm, which became Elanco, and Phibro competes by focusing on farm animals and medicated feed rather than the pet market that drives bigger rivals.


Phibro is small and has had a rocky patch financially, but it pays shareholders a dividend and funds its operations and acquisitions from cash flow. Its latest big move was buying the animal health business of Cargill, a deal that expanded its footprint in vaccines and medications. The bet is simple: feed the world, keep its animals well, and collect a reliable cut along the way.

Saved answer 路 last researched 15 Nov 2026